Literature DB >> 24702535

Prevalence and Risk Factors of Central Venous Stenosis among Prevalent Hemodialysis Patients, a Single Center Experience.

Osama O Osman1, Abdul-Rahman A El-Magzoub2, Sarra Elamin2.   

Abstract

INTRODUCTION: Central vein stenosis (CVS) is a common complication of central venous catheter (CVC) insertion. In this study we evaluated the prevalence and risk factors of CVS among hemodialysis (HD) patients in a single center in Sudan, using Doppler ultrasound as a screening tool.
METHODS: The study included 106 prevalent HD patients. For every patient, we performed Duplex Doppler for the right and left jugular, subclavian and femoral veins. A patient was considered to have hemodynamically significant stenosis if the pre-stenosis to the post-stenosis velocities ratio was ≥ 2.5 or they had complete vein occlusion.
RESULTS: Overall, 28.3% of patients had Doppler detected CVS, including 25.5% with hemodynamically significant stenosis and 2.8% with compromised flow. The prevalence of CVS was 68.4% among symptomatic patients compared to 19.5% in asymptomatic patients. The prevalence of CVS among patients with history of 0-1, 2-3 and ≥ 4 central venous catheters was 3.4%, 29.4% and 53.8% respectively (p=0.00). CVS was not more common in patients with history of previous/current jugular or femoral vein catheterization compared to no catheter placement in these veins (28.3% vs 28.6% and 35% vs 26.7% respectively; p >0.1). However, CVS was significantly more common in patients with previous/ current subclavian vein catheterization compared to no catheter placement in this vein (47.8% vs 22.9%, p = 0.02).
CONCLUSION: CVS is highly prevalent among studied HD patients, particularly in the presence of suggestive clinical signs. The number of HD catheter placements and subclavian vein utilization for dialysis access impose a significantly higher risk of CVS.

Entities:  

Mesh:

Year:  2014        PMID: 24702535

Source DB:  PubMed          Journal:  Arab J Nephrol Transplant


  7 in total

1.  Prevalence of Central Vein Stenosis in Patients Referred for Vein Mapping.

Authors:  Fasika M Tedla; Guerrier Clerger; Dale Distant; Moro Salifu
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-08       Impact factor: 8.237

2.  Radiologists need to be aware of secondary central venous stenosis in patients with SAPHO syndrome.

Authors:  Mizuho Suzuki; Hidenori Kanazawa; Takeshi Shinozaki; Hideharu Sugimoto
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

3.  Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis.

Authors:  Anamika Adwaney; Charlotte Lim; Sarah Blakey; Neill Duncan; Damien R Ashby
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-14       Impact factor: 8.237

4.  Hemodialysis Tunneled Catheter Noninfectious Complications.

Authors:  Lisa M Miller; Jennifer M MacRae; Mercedeh Kiaii; Edward Clark; Christine Dipchand; Joanne Kappel; Charmaine Lok; Rick Luscombe; Louise Moist; Matthew Oliver; Pamela Pike; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

5.  One-year outcomes and predictive factors for primary patency after stent placement for treatment of central venous occlusive disease in hemodialysis patients.

Authors:  Bin Chen; Run Lin; Haitao Dai; Jianyong Yang; Keyu Tang; Nan Li; Yonghui Huang
Journal:  Ther Adv Chronic Dis       Date:  2022-02-17       Impact factor: 5.091

6.  Clinical Implications of Phenotypes of Hemodialysis Patients With Central Venous Occlusion or Central Venous Stenosis Defined by Cluster Analysis.

Authors:  Chunyong Wen; Bin Chen; Run Lin; Haitao Dai; Keyu Tang; Guiyuan Zhang; Jiawen Huang; Changli Liao; Linyuan Zeng; Xianhong Xiang; Jianyong Yang; Yonghui Huang
Journal:  Front Cardiovasc Med       Date:  2022-06-20

7.  Reversible Encephalopathy Due to Venous Hypertension From Arteriovenous Hemodialysis Graft.

Authors:  Maria Antonietta Mazzola; Anil Ramineni; Joseph D Burns; David P Lerner
Journal:  Neurohospitalist       Date:  2020-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.